Global Tissue Engineered Skin Substitute Industry to 2027 – Featuring BSN Medical, Medtronic and MiMedx, Among Others – | Nation/World

DUBLIN–(BUSINESS WIRE)–January 25, 2022–

The report “Global Tissue Engineered Skin Substitutes Market (2021-2027) by Biomaterial, Anatomical Structure, Product Type, Application, Technology, Duration, End User, and Geography, IGR Competitive Analysis, Covid-19 Impact, Analysis Ansoff” has been added to the offering.

The Global Tissue Engineered Skin Substitutes Market is estimated to be valued at USD 745.3 Million in 2021 and is projected to reach USD 953.98 Million by 2027, growing at a CAGR of 4.2%.

Key factors, such as growing prevalence of acute and chronic wounds, rising incidence of burns and trauma, increasing demand for skin grafts, and increasing attention to technological advancements have led to an increase in the market for tissue-engineered skin substitutes. The increase in the number of patients with diabetic and vascular ulcers also drives the need for tissue engineering.

Growing awareness of various treatment options, the ability of tissue engineering to replace conventional autografts and allografts is also fueling the demand for tissue-engineered skin substitutes.

However, factors such as lack of proper reimbursement policies, high cost of treatment, and prolonged duration of treatment are hampering the growth of the market. Issues with biomaterials used for skin grafting such as biomaterial-centric infection and poor tissue integration can pose a challenge for the market growth.

The global tissue engineered skin substitutes market is segmented on the basis of biomaterial, anatomical structure, product type, application, technology, term, end-user, and geography .

Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and assess the position of companies based on their industry position score and market performance score. The tool uses various factors to classify players into four categories. Some of these factors considered for analysis are financial performance over the past 3 years, growth strategies, innovation score, new product launches, investments, market share growth, etc

Why buy this report?

  • The report offers a comprehensive assessment of the global tissue engineered skin substitutes market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and market size projections. Projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The main research is done through interviews, surveys and observations of renowned personnel in the industry.
  • The report includes an in-depth analysis of the market using Porter’s 5 forces model and Ansoff’s matrix. The impact of Covid-19 on the market is also presented in the report.
  • The report also contains competitive analysis using the Competitive Quadrant, the publisher’s proprietary competitive positioning tool.

Market dynamics


  • Increased prevalence of acute and chronic wounds
  • Growing demand for skin grafts
  • Growing awareness of various treatment options
  • Growing adoption and appropriate alternative to autografts and allografts
  • Increasing incidences of accidents, such as road accidents, burns and trauma


  • Lack of proper refund policies
  • High cost of treatment and prolonged treatment duration
  • Inability of biologists, biochemists and technical engineers to reproduce dander


  • Focus of researchers on establishing new construction technologies in the field of skin tissue engineering


  • Difficulty in producing complex skin substitutes that can be easily transplanted in large quantities
  • Problems with biomaterials used for skin grafts
  • Challenges in finding a substitute for split-thickness grafts


  • 3D bio-textiles and bio-printing

Companies cited

  • Organogenesis, Inc.
  • Blacksmith and nephew
  • BSN Medical
  • Molnlycke Healthcare
  • Integra LifeSciences
  • Medtronic
  • Regenix Fabrics Ltd
  • Stratatech (a Mallinckrodt company)
  • Regenicin
  • MiMedx
  • LifeNet Health
  • Kerecis
  • Medline Industries, Inc.
  • ConvaTec Group
  • Mallinckrodt
  • Amarantus Bioscience Holdings
  • 3M Inc.

For more information about this report visit

See the source version on


Laura Wood, Senior Press Officer

[email protected]

For EST business hours, call 1-917-300-0470

For US/CAN call toll free 1-800-526-8630

For GMT office hours call +353-1-416-8900



SOURCE: Research and Markets

Copyright BusinessWire 2022.

PUBLISHED: 01/25/2022 07:38 / DISK: 01/25/2022 07:38

Copyright BusinessWire 2022.